Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Treatment with chemotherapy or radiation is not invariably cytotoxic to all tumor cells. Some of the cells that survive treatment recover and resume proliferation, whereas others undergo permanent growth arrest. To understand the nature of treatment-induced terminal growth arrest, colon carcinoma cells were exposed to doxorubicin, and surviving cells were separated into proliferating and growth-arrested populations. Only growth-arrested cells displayed phenotypic markers of cell senescence and failed to form colonies. Gene expression was compared between senescent and proliferating fractions of drug-treated cells by using cDNA microarray hybridization and reverse transcription–PCR. Drug-induced senescence was associated with inhibition of genes involved in cell proliferation and with coinduction of multiple intracellular and secreted growth inhibitors. Several tumor suppressors and other genes that are down-regulated in carcinogenesis were up-regulated in senescent tumor cells. Induction of most growth inhibitors was delayed but not abolished in cells with homozygous knockout of p53, in agreement with only limited p53 dependence of drug-induced terminal growth arrest. On the other hand, senescent cells overexpressed secreted proteins with antiapoptotic, mitogenic, and angiogenic activities, suggesting that drug-induced senescence is associated with paracrine tumor-promoting effects. About one-third of the genes up-regulated in senescent cells and almost all of the down-regulated genes showed decreased or delayed changes in p21 Waf1/Cip1/Sdi1 -deficient cells, indicating that p21 is a major mediator of the effects of p53 on gene expression. Elucidation of molecular changes in tumor cells that undergo drug-induced senescence suggests potential strategies for diagnostics and therapeutic modulation of this antiproliferative response in cancer treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Many types of cytotoxic chemotherapies are severe DNA-damaging agents that can induce senescence in both tumor cells and surrounding normal cells (31–34).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [31]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Senescent cells acquire many changes in gene expression, mostly documented as altered mRNA abundance, including increased expression of secreted proteins [ 33 – 41 ].”
From Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor (2008) · cites this paper as [34]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Requirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage
Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B. (1998) · Science · doi:10.1126/science.282.5393.1497 · Cited by 2,803
Di Leonardo, A., Linke, S. P., Clarkin, K., & Wahl, G. M. (1994) · Genes & Development · doi:10.1101/gad.8.21.2540 · Cited by 1,215
Alcorta, D. A., Xiong, Y., Phelps, D., Hannon, G., Beach, D., & Barrett, J. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13742 · Cited by 1,008
PML regulates p53 acetylation and premature senescence induced by oncogenic Ras
Pearson, M., Carbone, R., Sebastiani, C., Cioce, M., Fagioli, M., Saito, S., Higashimoto, Y., Appella, E., Minucci, S., Pandolfi, P. P., et al. (2000) · Nature · doi:10.1038/35018127 · Cited by 847
Jordan, M. A., Wendell, K., Gardiner, S., Derry, W. B., Copp, H., & Wilson, L. (1996) · PubMed · Cited by 770
Noonan, K. E., Beck, C., Holzmayer, T. A., Chin, J. E., Wunder, J. S., Andrulis, I. L., Gazdar, A. F., Willman, C. L., Griffith, B., Von Hoff, D. D., et al. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.18.7160 · Cited by 714
Self-citationMitotic Misregulation and Human Aging
Ly, D. H., Lockhart, D. J., Lerner, R. A., & Schultz, P. G. (2000) · Science · doi:10.1126/science.287.5462.2486 · Cited by 599
Mutations truncating the EP300 acetylase in human cancers
Gayther, S. A., Batley, S. J., Linger, L., Bannister, A., Thorpe, K., Chin, S.-F., Daigo, Y., Russell, P., Wilson, A., Sowter, H. M., et al. (2000) · Nature Genetics · doi:10.1038/73536 · Cited by 587
Research works printed but not linked: 6
- B D Chang, E V Broude, M Dokmanovic, H Zhu, A Ruth, Y Xuan, E S Kandel, E Lausch, K Christov, I B Roninson Cancer Res 59, 3761–3767 (1999).
- J Campisi In Vivo (Athens, Greece) 14, 183–188 (2000).
- M A Jordan, K Wendell, S Gardiner, W B Derry, H Copp, L Wilson Cancer Res 56, 816–825 (1996).
- S K Myohanen, S B Baylin, J G Herman Cancer Res 58, 591–593 (1998).
- T Waldman, K W Kinzler, B Vogelstein Cancer Res 55, 5187–5190 (1995).
- Dotto, G. P. (2000) Biochim. Biophys. Acta 1471, M43-M56.
Cited by
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Aging, Cellular Senescence, and Cancer
Campisi, J. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183653 · Cited by 2,954
Laberge, R.-M., Sun, Y., Orjalo, A. V., Patil, C. K., Freund, A., Zhou, L., Curran, S. C., Davalos, A. R., Wilson-Edell, K. A., Liu, S., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3195 · Cited by 1,160
Apoptosis and melanoma chemoresistance
Soengas, M. S., & Lowe, S. W. (2003) · Oncogene · doi:10.1038/sj.onc.1206454 · Cited by 826
Therapy-induced senescence in cancer.
Ewald, J. A., Desotelle, J. A., Wilding, G., & Jarrard, D. F. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djq364 · Cited by 824
“A comparison of TIS in cancer cells containing functional p53 or a homozygous knockout demonstrated similar robust responses, indicating limited p53 dependence in drug-induced senescence (44,45).”
BackgroundResultInfluentialIndividuality and variation in gene expression patterns in human blood
Whitney, A. R., Diehn, M., Popper, S. J., Alizadeh, A. A., Boldrick, J. C., Relman, D. A., & Brown, P. O. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252784499 · Cited by 778
Biomarkers, oxidative stress and autophagy in skin aging
Gu, Y., Han, J., Jiang, C., & Zhang, Y. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101036 · Cited by 762
Radiation-induced cell death mechanisms
Eriksson, D., & Stigbrand, T. (2010) · Tumor Biology · doi:10.1007/s13277-010-0042-8 · Cited by 666
Senescent cells as a source of inflammatory factors for tumor progression
Davalos, A. R., Coppe, J.-P., Campisi, J., & Desprez, P.-Y. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9220-9 · Cited by 636
(2003) · PubMed · Cited by 608
Self-citationHallmarks of senescence in carcinogenesis and cancer therapy
Shay, J. W., & Roninson, I. B. (2004) · Oncogene · doi:10.1038/sj.onc.1207518 · Cited by 502
“Since p53- and p21-null cells are still able to undergo drug-induced senescence (albeit at a diminished rate) (Chang et al., 1999b), inhibition of cell cycle progression genes does not appear to be an absolute requirement for this arrest (Chang et al., 2002).”
BackgroundInfluentialSelf-citationSoriani, A., Zingoni, A., Cerboni, C., Iannitto, M. L., Ricciardi, M. R., Di Gialleonardo, V., Cippitelli, M., Fionda, C., Petrucci, M. T., Guarini, A., et al. (2009) · Blood · doi:10.1182/blood-2008-08-173914 · Cited by 460
Coppé, J.-P., Patil, C. K., Rodier, F., Krtolica, A., Beauséjour, C. M., Parrinello, S., Hodgson, J. G., Chin, K., Desprez, P.-Y., & Campisi, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009188 · Cited by 455
“To date, only the SASPs of human cells have been well characterized [15,27,28,30,33,34,35,36].”
BackgroundRoninson, I. B. (2002) · Cancer Letters · doi:10.1016/s0304-3835(01)00847-3 · Cited by 443
Self-citationRoberson, R. S., Kussick, S. J., Vallieres, E., Chen, S.-Y. J., & Wu, D. Y. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1270 · Cited by 428
The power and the promise of oncogene-induced senescence markers
Collado, M., & Serrano, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1884 · Cited by 404
“However, it has been known for a long time that chemotherapeutic drugs can also trigger senescence, occasionally named chemotherapy-induced premature senescenc”
BackgroundCritical pathways in cellular senescence and immortalization revealed by gene expression profiling
Fridman, A. L., & Tainsky, M. A. (2008) · Oncogene · doi:10.1038/onc.2008.213 · Cited by 385
“IGFBP6 mRNA expression increased in the senescent colon carcinoma cell line HCT116 (Chang et al., 2002).”
BackgroundEom, Y.-W., Kim, M. A., Park, S. S., Goo, M. J., Kwon, H. J., Sohn, S., Kim, W.-H., Yoon, G., & Choi, K. S. (2005) · Oncogene · doi:10.1038/sj.onc.1208627 · Cited by 351
Coppé, J.-P., Patil, C. K., Rodier, F., Sun, Y., Muñoz, D. P., Goldstein, J., Nelson, P. S., Desprez, P.-Y., & Campisi, J. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060301 · Cited by 302
“expression of secreted proteins [33–41].”
Senescence, apoptosis and therapy — cutting the lifelines of cancer
Schmitt, C. A. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1044 · Cited by 295
Accelerated senescence: An emerging role in tumor cell response to chemotherapy and radiation
Gewirtz, D. A., Holt, S. E., & Elmore, L. W. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.06.024 · Cited by 281
Cellular senescence and cancer treatment
Schmitt, C. A. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.08.005 · Cited by 254
Suppressing Cancer: The Importance of Being Senescent
Campisi, J. (2005) · Science · doi:10.1126/science.1116801 · Cited by 249
Sullivan, R., Paré, G. C., Frederiksen, L. J., Semenza, G. L., & Graham, C. H. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0198 · Cited by 243
Tumor suppressors BTG1 and BTG2: Beyond growth control
Yuniati, L., Scheijen, B., van der Meer, L. T., & van Leeuwen, F. N. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27407 · Cited by 229
Measuring Aging and Identifying Aging Phenotypes in Cancer Survivors
Guida, J. L., Ahles, T. A., Belsky, D., Campisi, J., Cohen, H. J., DeGregori, J., Fuldner, R., Ferrucci, L., Gallicchio, L., Gavrilov, L., et al. (2019) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djz136 · Cited by 216
Debey, S., Schoenbeck, U., Hellmich, M., Gathof, B. S., Pillai, R., Zander, T., & Schultze, J. L. (2004) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500240 · Cited by 213
Caspase inhibition switches doxorubicin-induced apoptosis to senescence
Rebbaa, A., Zheng, X., Chou, P. M., & Mirkin, B. L. (2003) · Oncogene · doi:10.1038/sj.onc.1206366 · Cited by 201
Tumor cell escape from therapy-induced senescence
Saleh, T., Tyutyunyk-Massey, L., Murray, G. F., Alotaibi, M. R., Kawale, A. S., Elsayed, Z., Henderson, S. C., Yakovlev, V., Elmore, L. W., Toor, A., et al. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.12.013 · Cited by 182
Induction of senescence with doxorubicin leads to increased genomic instability of HCT116 cells
Sliwinska, M. A., Mosieniak, G., Wolanin, K., Babik, A., Piwocka, K., Magalska, A., Szczepanowska, J., Fronk, J., & Sikora, E. (2009) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.04.011 · Cited by 178
Nam, J., La, W.-G., Hwang, S., Ha, Y. S., Park, N., Won, N., Jung, S., Bhang, S. H., Ma, Y.-J., Cho, Y.-M., et al. (2013) · ACS Nano · doi:10.1021/nn400223a · Cited by 178
Signaling Pathways of the Insulin-like Growth Factor Binding Proteins
Baxter, R. C. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad008 · Cited by 178
Resveratrol Induces Premature Senescence in Lung Cancer Cells via ROS-Mediated DNA Damage
Luo, H., Yang, A., Schulte, B. A., Wargovich, M. J., & Wang, G. Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060065 · Cited by 176
Ellagic acid induced p53/p21 expression, G1 arrest and apoptosis in human bladder cancer T24 cells.
Li, T., Chen, G.-W., Su, C., Lin, J.-G., Yeh, C.-C., Cheng, K.-C., & Chung, J. (2005) · PubMed · Cited by 173
Cyclin-dependent kinase 8 mediates chemotherapy-induced tumor-promoting paracrine activities
Porter, D. C., Farmaki, E., Altilia, S., Schools, G. P., West, D. K., Chen, M., Chang, B.-D., Puzyrev, A. T., Lim, C.-U., Rokow-Kittell, R., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206906109 · Cited by 172
“Notably, Senexin A did not inhibit doxorubicin-induced expression of Maspin, a tumor suppressor protein that is upregulated by damage through a p21-independent pathway (11) (Fig.”
BackgroundSelf-citationSelimović, D., Porzig, B. B. O. W., El‐Khattouti, A., Badura, H. E., Ahmad, M., Ghanjati, F., Santourlidis, S., Haïkel, Y., & Hassan, M. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.10.004 · Cited by 164
Variation in gene expression profiles of peripheral blood mononuclear cells from healthy volunteers
Eady, J. J., Wortley, G. M., Wormstone, Y. M., Hughes, J. C., Astley, S. B., Foxall, R. J., Doleman, J. F., & Elliott, R. M. (2005) · Physiological Genomics · doi:10.1152/physiolgenomics.00080.2005 · Cited by 162
Chu, F., Chou, P. M., Zheng, X., Mirkin, B. L., & Rebbaa, A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2002 · Cited by 161
Senescent fibroblasts resist apoptosis by downregulating caspase-3.
Marcotte, R., Lacelle, C., & Wang, E. (2004) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2004.07.007 · Cited by 159
Elmore, L. W., Di, X., Dumur, C., Holt, S. E., & Gewirtz, D. A. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1462 · Cited by 151
Huang, X., Tran, T., Zhang, L., Hatcher, R., & Zhang, P. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409130102 · Cited by 147
Seresht, H. R., Cheshomi, H., Falanji, F., Motlagh, F. M., Hashemian, M., & Mireskandari, E. (2019) · PubMed Central · doi:10.22038/ajp.2019.13475 · Cited by 147
Hsp27 Modulates p53 Signaling and Suppresses Cellular Senescence
O’Callaghan-Sunol, C., Gabai, V. L., & Sherman, M. Y. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2441 · Cited by 144
Cell cycle control and beyond: emerging roles for the retinoblastoma gene family
Genovese, C., Trani, D., Caputi, M., & Claudio, P. P. (2006) · Oncogene · doi:10.1038/sj.onc.1209652 · Cited by 144
Gene Expression Profiling in Non-Small Cell Lung Cancer
Petty, R., Nicolson, M. C., Kerr, K. M., Collie-Duguid, E. S. R., & Murray, G. I. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0503 · Cited by 142
Mitotic Catastrophe Results in Cell Death by Caspase-Dependentand Caspase-Independent Mechanisms
Mansilla, S., Priebe, W., & Portugal, J. (2006) · Cell Cycle · doi:10.4161/cc.5.1.2267 · Cited by 140
Schwarze, S. R., Fu, V. X., Desotelle, J. A., Kenowski, M. L., & Jarrard, D. F. (2005) · Neoplasia · doi:10.1593/neo.05250 · Cited by 139
Cellular senescence and cancer chemotherapy resistance
Gordon, R. R., & Nelson, P. S. (2012) · Drug Resistance Updates · doi:10.1016/j.drup.2012.01.002 · Cited by 134
Biology of Cancer and Aging: A Complex Association With Cellular Senescence
Falandry, C., Bonnefoy, M., Freyer, G., & Gilson, E. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.1432 · Cited by 128
Stress-induced Premature Senescence (SIPS)
SUZUKI, M., & BOOTHMAN, D. A. (2008) · Journal of Radiation Research · doi:10.1269/jrr.07081 · Cited by 126
Wong, Y. F., Selvanayagam, Z., Wei, N., Porter, J. F., Vittal, R., Hu, R., Lin, Y., Liao, J. J. Z., Shih, J. W., Cheung, T. H., et al. (2003) · PubMed · Cited by 126
Generation of an epigenetic signature by chronic hypoxia in prostate cells
Watson, J. A., Watson, C. J., McCrohan, A., Woodfine, K., Tosetto, M., McDaid, J., Gallagher, E., Betts, D., Baugh, J. A., O'Sullivan, J. N., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp307 · Cited by 122
Leontieva, O. V., & Blagosklonny, M. V. (2013) · Cell Cycle · doi:10.4161/cc.26130 · Cited by 117
Peiris-Pagès, M., Sotgia, F., & Lisanti, M. P. (2015) · Oncotarget · doi:10.18632/oncotarget.3828 · Cited by 115
The Paradoxical Role of Cellular Senescence in Cancer
Yang, J., Liu, M., Hong, D., Zeng, M., & Zhang, X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.722205 · Cited by 114
Hypoxia-Induced Resistance to Chemotherapy in Cancer
Minassian, L. M., Cotechini, T., Huitema, E., & Graham, C. H. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-12734-3_9 · Cited by 114
IGFBP-6 five years on; not so ‘forgotten’?
Bach, L. A. (2005) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2005.04.001 · Cited by 112
Heat Shock Protein Hsp72 Controls Oncogene-Induced Senescence Pathways in Cancer Cells
Gabai, V. L., Yaglom, J. A., Waldman, T., & Sherman, M. Y. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01041-08 · Cited by 112
Biological functions of therapy-induced senescence in cancer
Fitsiou, E., Soto-Gamez, A., & Demaria, M. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.03.021 · Cited by 111
Extensive Proliferation of Human Cancer Cells with Ever-Shorter Telomeres
Dagg, R. A., Pickett, H. A., Neumann, A. A., Napier, C. E., Henson, J. D., Teber, E. T., Arthur, J. W., Reynolds, C. P., Murray, J., Haber, M., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.05.087 · Cited by 110
Lehmann, B. D., McCubrey, J. A., Jefferson, H. S., Paine, M. S., Chappell, W. H., & Terrian, D. M. (2007) · Cell Cycle · doi:10.4161/cc.6.5.3901 · Cited by 106
Gabai, V. L., Meng, L., Kim, G., Mills, T. A., Benjamin, I. J., & Sherman, M. Y. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.05921-11 · Cited by 105
Karabicici, M., Alptekin, S., Karagonlar, Z. F., & Erdal, E. (2021) · Molecular Oncology · doi:10.1002/1878-0261.12916 · Cited by 104
Identification of Candidate Biomarkers of Therapeutic Response to Docetaxel by Proteomic Profiling
Zhao, L., Lee, B. Y., Brown, D. A., Molloy, M. P., Marx, G. M., Pavlakis, N., Boyer, M. J., Stockler, M. R., Kaplan, W., Breit, S. N., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4901 · Cited by 104
Insulin-like growth factor-binding protein-6 and cancer
Bach, L. A., Fu, P., & Yang, Z. (2012) · Clinical Science · doi:10.1042/cs20120343 · Cited by 104
Li, X. L., Hara, T., Choi, Y., Subramanian, M., Francis, P., Bilke, S., Walker, R. L., Pineda, M., Zhu, Y., Yang, Y., et al. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01043-13 · Cited by 101
Shen, W., Liu, L., & Zeng, S. (2018) · Cancer translational medicine · doi:10.4103/ctm.ctm_22_18 · Cited by 98
Recent insights into the actions of IGFBP-6
Bach, L. A. (2015) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-015-0288-4 · Cited by 97
Molecular Regulation of Melanocyte Senescence
Bennett, D. C., & Medrano, E. E. (2002) · Pigment Cell Research · doi:10.1034/j.1600-0749.2002.02036.x · Cited by 95
p21Waf1/Cip1/Sdi1 mediates retinoblastoma protein degradation
Broude, E. V., Swift, M. E., Vivo, C., Chang, B.-D., Davis, B. M., Kalurupalle, S., Blagosklonny, M. V., & Roninson, I. B. (2007) · Oncogene · doi:10.1038/sj.onc.1210516 · Cited by 94
Self-citationCell death in irradiated prostate epithelial cells: role of apoptotic and clonogenic cell kill
Bromfield, G. P., Meng, A., Warde, P. R., & Bristow, R. G. (2003) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500628 · Cited by 95
Role of the p53/p21 system in the response of human colon carcinoma cells to Doxorubicin
Ravizza, R., Gariboldi, M. B., Passarelli, L., & Monti, E. (2004) · BMC Cancer · doi:10.1186/1471-2407-4-92 · Cited by 94
The Roles of Autophagy and Senescence in the Tumor Cell Response to Radiation
Patel, N. H., Sohal, S. S., Manjili, M. H., Harrell, J. C., & Gewirtz, D. A. (2020) · Radiation Research · doi:10.1667/rade-20-00009 · Cited by 93
Jackson, M. W., Agarwal, M. K., Yang, J., Bruss, P., Uchiumi, T., Agarwal, M. L., Stark, G. R., & Taylor (2005) · Journal of Cell Science · doi:10.1242/jcs.02307 · Cited by 92
Martínková, E., Maglott, A., Leger, D. Y., Bonnet, D., Stiborová, M., Takeda, K., Martin, S., & Dontenwill, M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25187 · Cited by 92
Resistance and gain-of-resistance phenotypes in cancers harboring wild-type p53
Martinez-Rivera, M., & Siddik, Z. H. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.12.026 · Cited by 93
Rastogi, S., Joshi, B., Dasgupta, P., Morris, M., Wright, K., & Chellappan, S. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.02142-05 · Cited by 90
Senescence-initiated Reversal of Drug Resistance
Zheng, X. S., Chou, P. M., Mirkin, B. L., & Rebbaa, A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-0820 · Cited by 89
Cellular Senescence in the Development and Treatment of Cancer
Saretzki, G. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210789941874 · Cited by 87
Replicative senescence revisited.
Marcotte, R., & Wang, E. (2002) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/57.7.b257 · Cited by 86
Crescenzi, E., Palumbo, G. A., de Boer, J., & Brady, H. J. M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4298 · Cited by 88
Gene expression microarray technologies in the development of new therapeutic agents
Clarke, P. A., Poele, R. T., & Workman, P. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.07.024 · Cited by 86
Shabbeer, S., Kortenhorst, M. S. Q., Kachhap, S. K., Galloway, N. L., Rodriguez, R., & Carducci, M. A. (2007) · The Prostate · doi:10.1002/pros.20587 · Cited by 85
Novel roles of prolactin and estrogens in breast cancer: resistance to chemotherapy
LaPensee, E. W., & Ben‐Jonathan, N. (2010) · Endocrine Related Cancer · doi:10.1677/erc-09-0253 · Cited by 84
Identification of midkine as a mediator for intercellular transfer of drug resistance
Mirkin, B. L., Clark, S. H., Zheng, X. S., Chu, F., White, B. D., Greene, M. E., & Rebbaa, A. (2005) · Oncogene · doi:10.1038/sj.onc.1208671 · Cited by 81
Crescenzi, E., Chiaviello, A., Canti, G., Reddi, E., Veneziani, B. M., & Palumbo, G. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0425 · Cited by 80
hCLCA2 Is a p53-Inducible Inhibitor of Breast Cancer Cell Proliferation
Walia, V., Ding, M., Kumar, S., Nie, D., Premkumar, L. S., & Elble, R. C. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4101 · Cited by 75
Chemotherapy response and resistance
Lee, S., & Schmitt, C. A. (2003) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00014-x · Cited by 73
Emerging role of anti-proliferative protein BTG1 and BTG2
Kim, S., Jung, I. R., & Hwang, S. S. (2022) · BMB Reports · doi:10.5483/bmbrep.2022.55.8.092 · Cited by 72
Rebbaa, A., Chu, F., Davis, F. B., Davis, P. J., & Mousa, S. A. (2008) · Angiogenesis · doi:10.1007/s10456-008-9110-8 · Cited by 70
Duale, N., Lindeman, B., Komada, M., Olsen, A.-K. H., Andreassen, Å. K., Søderlund, E. J., & Brunborg, G. (2007) · Molecular Cancer · doi:10.1186/1476-4598-6-53 · Cited by 69
Guo, Q. M. (2003) · Current Opinion in Oncology · doi:10.1097/00001622-200301000-00005 · Cited by 69
Dhaheri, Y. A., Attoub, S., Arafat, K., AbuQamar, S. F., Eid, A. H., Faresi, N. A., & Iratni, R. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.01.010 · Cited by 68
Nickoloff, B. J., Lingen, M. W., Chang, B.-D., Shen, M., Swift, M., Curry, J., Bacon, P., Bodner, B., & Roninson, I. B. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2388 · Cited by 67
Self-citationHatse, S., Brouwers, B., Dalmasso, B., Laenen, A., Kenis, C., Schöffski, P., & Wildiers, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110644 · Cited by 67
Identification and immunotherapeutic targeting of antigens induced by chemotherapy
Rubinfeld, B., Upadhyay, A., Clark, S., Fong, S., Smith, V., Koeppen, H., Ross, S., & Polakis, P. G. (2006) · Nature Biotechnology · doi:10.1038/nbt1185 · Cited by 67
Cell Death Pathways in Response to Antitumor Therapy
Portugal, J., Bataller, M., & Mansilla, S. (2009) · Tumori Journal · doi:10.1177/030089160909500401 · Cited by 67
Conditional Deletion of Insulin-like Growth Factor-I Receptor in Prostate Epithelium
Sutherland, B. W., Knoblaugh, S. E., Kaplan-Lefko, P. J., Wang, F., Holzenberger, M., & Greenberg, N. M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6531 · Cited by 66
Luo, H., Yount, C., Lang, H., Yang, A., Riemer, E. C., Lyons, K., Vanek, K. N., Silvestri, G. A., Schulte, B. A., & Wang, G. Y. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.04.017 · Cited by 66
Metadata
- Authors
- Chang, B.-D., Swift, M. E., Shen, M., Fang, J., Broude, E. V., & Roninson, I. B.
- Affiliations
- University of Illinois Chicago (US)
- Corresponding author
- Roninson, Igor B.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2001-12-18
- Volume
- 99
- Issue
- 1
- Pages
- 389-394
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC117570
- OpenAlex
- W2162118018
- Cited by
- 312
- References
- 39
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 10 · 2023: 11 · 2022: 10 · 2021: 10 · 2020: 12 · 2019: 9 · 2018: 12 · 2017: 6 · 2016: 8 · 2015: 10 · 2014: 6 · 2013: 13 · 2012: 16
- FWCI
- 7.51
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r37ca040333-15)
- National Cancer Institute (R37 CA 40333, R01CA089636, R01CA062099)
- National Institute of Diabetes and Digestive and Kidney Diseases (T32 DK0773909)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- drug-induced senescence, doxorubicin, colon cancer cells, p53, tumor suppressor, growth inhibitors, anti-apoptotic factors, angiogenic factors, chemoresistance, gene expression profiling
- MeSH terms
- Animals, Antineoplastic Agents, Cell Division, Doxorubicin, Humans, Neoplasms, Phenotype, RNA, Messenger, Time Factors, Tumor Cells, Cultured, Down-Regulation, Up-Regulation, Genes, p53, Proto-Oncogene Proteins p21(ras), Cellular Senescence, DNA, Complementary, Reverse Transcriptase Polymerase Chain Reaction, Oligonucleotide Array Sequence Analysis, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.